Daniel Geffken, MBA
Chief Financial Officer (Interim)
Daniel Geffken, MBA, is a proven leader of life science companies with more than 30 years of experience steering strategy, finance and operations across all stages of the corporate life cycle. As co-founder and Managing Director of Danforth Advisors, he leads a team of more than 90 consultants in strategic CFO advisory, accounting and operational support for over 150 clients, ranging from life science start-ups to publicly traded companies with $1 billion+ market capitalizations. He has served as CFO and executive-level advisor to numerous companies, including Apellis Pharmaceuticals, Cabaletta Bio, Cidara Therapeutics, Editas Medicine, Homology Medicines, Promedior, ProMIS Neurosciences, and Stealth BioTherapeutics.